Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1707 results
An image of a darts board with a dart hitting the bulls-eye.

In part 4 of our radiotherapy series we look at MRI-guided radiotherapy, and how it could help improve accuracy and reduce side effects. In part 4 of our radiotherapy series we look at MRI-guided radiotherapy, and how it could help improve accuracy and reduce side effects.

by Michael Walsh | Analysis | 8 August 2017

8 August 2017

This entry is part 4 of 11 in the series Radiotherapy
%postcontent%

New research into the genetic and molecular features of cancers that have spread has revealed the diversity of these tumours and the immune cells within. New research into the genetic and molecular features of cancers that have spread has revealed the diversity of these tumours and the immune cells within.

by In collaboration with PA Media Group | News | 3 August 2017

3 August 2017

Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease. Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease.

by Cancer Research UK | News | 3 August 2017

3 August 2017

Radiotherapy

Part 3 of our radiotherapy series explores a type of radiotherapy treatment called IMRT. But what is it and can it help improve survival? We take a look. Part 3 of our radiotherapy series explores a type of radiotherapy treatment called IMRT. But what is it and can it help improve survival? We take a look.

by Gabriella Beer | Analysis | 31 July 2017

31 July 2017

This entry is part 3 of 11 in the series Radiotherapy
%postcontent%

Scientists have devised a simple test for an earlier and more accurate warning of returning bladder cancer than existing methods. Scientists have devised a simple test for an earlier and more accurate warning of returning bladder cancer than existing methods.

by British Journal of Cancer | News | 7 July 2017

7 July 2017

New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t. New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.

by Justine Alford | Analysis | 27 June 2017

27 June 2017